Blog
EQS-News: Stabilus SE: Invitation to conference call on Q3 FY2023 results on July 31, 2023
EQS-News: Stabilus SE: Invitation to conference call on Q3 FY2023 results on July 31, 2023
EQS-Adhoc: PSI adjusts Outlook for 2023 Operating Result due to One-time Expenses
EQS-Adhoc: PSI adjusts Outlook for 2023 Operating Result due to One-time Expenses
EQS-News: Delivery Hero SE: Delivery Hero reinforces commitment to the Kingdom of Saudi Arabia by taking sole ownership of HungerStation
EQS-News: Delivery Hero SE: Delivery Hero reinforces commitment to the Kingdom of Saudi Arabia by taking sole ownership of HungerStation
EQS-News: Borussia Dortmund re-admitted to the SDAX
EQS-News: Borussia Dortmund re-admitted to the SDAX
029 Group SE: Portfolio company Hotelbird introduces a new fully automated kiosk solution
029 Group SE: Portfolio company Hotelbird introduces a new fully automated kiosk solution
Fix Price Group PLC: Notification of PDMR transaction
Fix Price Group PLC: Notification of PDMR transaction
Agreement on the sale of Hornsea 2 transmission assets
Agreement on the sale of Hornsea 2 transmission assets
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Fuller, Smith & Turner PLC: Share Buyback Programme
Fuller, Smith & Turner PLC: Share Buyback Programme
Polymetal: Update to the timetable of the Re-domiciliation
Polymetal: Update to the timetable of the Re-domiciliation
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA: Information on Document Availability
Lonza Delivers 5.6% CER Sales Growth, With Underlying Growth at Around 10% CER and 30% CORE EBITDA Margin
Lonza Delivers 5.6% CER Sales Growth, With Underlying Growth at Around 10% CER and 30% CORE EBITDA Margin
EQS-News: BB BIOTECH AG: Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry
EQS-News: BB BIOTECH AG: Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry
EQS-Adhoc: BB Biotech AG publishes its interim report
EQS-Adhoc: BB Biotech AG publishes its interim report
EQS-News: SARTORIUS AG: Sartorius maintains high profitability despite the expected temporary declines in the first half of 2023
EQS-News: SARTORIUS AG: Sartorius maintains high profitability despite the expected temporary declines in the first half of 2023
Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech
Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech
Gaining momentum
Gaining momentum
Bystronic AG: Enhanced profitability in the first half of 2023
Bystronic AG: Enhanced profitability in the first half of 2023
HBM Healthcare Investments publishes interim report for the quarter ended 30 June 2023 with key figures for the first three months of the 2023/2024 financial year
HBM Healthcare Investments publishes interim report for the quarter ended 30 June 2023 with key figures for the first three months of the 2023/2024 financial year
EQS-Adhoc: ACCENTRO Real Estate AG informs about potential change in its shareholder structure
EQS-Adhoc: ACCENTRO Real Estate AG informs about potential change in its shareholder structure
EQS-Adhoc: SURTECO GROUP SE: Adjustment of the forecast for 2023 due to one-off special effects and continued weak demand
EQS-Adhoc: SURTECO GROUP SE: Adjustment of the forecast for 2023 due to one-off special effects and continued weak demand
2CRSi SA: 2CRSi receives a grant of 1 million euros as part of the 'France 2030' plan.
2CRSi SA: 2CRSi receives a grant of 1 million euros as part of the 'France 2030' plan.
EQS-News: Traumhaus AG: Resolution on a capital increase from authorized capital excluding subscription rights
EQS-News: Traumhaus AG: Resolution on a capital increase from authorized capital excluding subscription rights
EQS-Adhoc: Traumhaus AG: Resolution on a capital increase from authorized capital excluding subscription rights
EQS-Adhoc: Traumhaus AG: Resolution on a capital increase from authorized capital excluding subscription rights


